「for」の検索結果
119件：86～90件目を表示
-
esident: Mr. Naoyuki Mochida; hereinafter: Mochida) and developed by Senju as an eye drop treatment for Dry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
sium, and calcium was made closer to normal tears. This medicine contains calcium that is important for maintaining the function and transparency of the cornea. pH, osmotic pressure ratio, and viscosi...
http://www.senju.co.jp/english/products/myteara.html -
2025 General Announcement: Senju Pharmaceutical Co., Ltd. Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drops Senju Pharmaceutical Co., Ltd. (Head Off...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. ...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
ral Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf